Command Palette

Search for a command to run...

BAJAJHCARE
457.8(-2.35%)
1W: -3.50%

Bajaj Healthcare Peer Comparison

Snapshot Summary

Bajaj Healthcare Ltd. stands out as a sector laggard due to its lack of revenue and earnings growth, zero return on equity, and no profitability metrics. In contrast, peers show significant growth, profitability, and valuation metrics, indicating a challenging position for Bajaj Healthcare within the sector.

  • Bajaj Healthcare has zero revenue and earnings growth, making it a laggard compared to peers.
  • Peers like Mankind Pharma and Dr. Reddy's Laboratories demonstrate strong growth and profitability.
  • Valuation metrics suggest Bajaj Healthcare is not a value pick given its poor performance.
  • Mankind Pharma Ltd.: Outstanding revenue growth (YoY: 18.12%), high profitability (ROE: 23.15%), and reasonable valuation metrics.
  • Dr. Reddy's Laboratories Ltd.: Strong profitability with a PE of 15.50 and ROE of 21.76%, coupled with good growth metrics.
  • Cipla Ltd.: Balanced growth (YoY: 13.28%), strong profitability (ROE: 16.63%), and attractive valuation metrics.
Stocks
CMP
Market Cap
P/E
ROCE (%)
Debt/Equity
BAJAJHCARE₹424.85₹1,341.82Cr28.50--
SUNPHARMA₹1,563.35₹3,75,099.26Cr87.5917.60%0.04
DIVISLAB₹6,091.05₹1,61,698.50Cr73.2016.46%-
CIPLA₹1,587.60₹1,28,217.27Cr23.7322.77%0.01
TORNTPHARM₹3,581.55₹1,21,215.77Cr61.5324.28%0.57
DRREDDY₹1,280.30₹1,06,835.27Cr15.5026.86%0.07
MANKIND₹2,518.95₹1,03,926.59Cr55.1828.38%0.02

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.